encapsulated Melligen cell therapy (PharmaCyte)

N/A

Report date: 2025/03/20 15:04:29

Base Information

Drug Nameencapsulated Melligen cell therapy (PharmaCyte)
Drug Alias Nameencapsulated Melligen cell therapy (Nuvilex)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmacyte Biotech
China Registration ClassN/A

Develop Information

Active CompaniesPharmacyte Biotech
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A